SecSonar.com

LENZ Therapeutics, Inc. (LENZ)

LENZ Therapeutics, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

LENZ Therapeutics, Inc. (LENZ) is a Biotechnology company based in US with a market capitalization of $249.3M. Free cash flow was negative at -$70M. This page tracks LENZ's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 6 employees · IPO Mar 22, 2024

Valuation

Valuation & price

$7.34 · as of May 17, 2026 · -85.0% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.88

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$48.60$27.09$5.58Jul 25Dec 25Jul 26Jul 7, 25$31.48Jul 9, 25$34.82Jul 11, 25$34.69Jul 15, 25$32.75Jul 17, 25$34.57Jul 21, 25$33.58Jul 23, 25$33.05Jul 25, 25$31.62Jul 29, 25$31.67Jul 31, 25$29.77Aug 4, 25$29.33Aug 6, 25$30.17Aug 11, 25$38.77Aug 13, 25$39.36Aug 15, 25$37.85Aug 19, 25$37.61Aug 21, 25$39.85Aug 25, 25$39.68Aug 27, 25$37.37Aug 29, 25$38.63Sep 3, 25$39.27Sep 5, 25$41.98Sep 9, 25$39.89Sep 11, 25$40.81Sep 16, 25$41.29Sep 18, 25$41.69Sep 22, 25$41.26Sep 24, 25$41.04Sep 26, 25$42.03Sep 30, 25$46.58Oct 2, 25$48.32Oct 6, 25$46.11Oct 8, 25$48.60Oct 10, 25$38.79Oct 14, 25$38.80Oct 16, 25$40.45Oct 21, 25$33.56Oct 23, 25$31.38Oct 27, 25$31.29Oct 29, 25$30.64Oct 31, 25$29.72Nov 4, 25$28.05Nov 6, 25$22.96Nov 10, 25$23.19Nov 12, 25$25.50Nov 14, 25$25.60Nov 18, 25$27.23Nov 20, 25$27.72Nov 25, 25$29.88Nov 28, 25$30.52Dec 2, 25$27.31Dec 4, 25$27.90Dec 8, 25$26.71Dec 10, 25$25.04Dec 12, 25$18.14Dec 16, 25$16.70Dec 18, 25$17.07Dec 22, 25$17.62Dec 24, 25$17.14Dec 29, 25$16.52Jan 2, 26$16.00Jan 6, 26$16.85Jan 8, 26$15.24Jan 12, 26$15.57Jan 14, 26$18.59Jan 16, 26$18.29Jan 21, 26$19.48Jan 23, 26$20.44Jan 27, 26$19.39Jan 29, 26$17.78Feb 2, 26$16.30Feb 4, 26$14.62Feb 9, 26$14.01Feb 11, 26$13.51Feb 13, 26$12.88Feb 18, 26$12.77Feb 20, 26$11.59Feb 24, 26$12.82Feb 26, 26$13.52Mar 2, 26$13.68Mar 4, 26$12.96Mar 6, 26$11.67Mar 10, 26$11.94Mar 12, 26$11.82Mar 17, 26$12.50Mar 19, 26$11.49Mar 23, 26$11.00Mar 25, 26$9.07Mar 27, 26$8.40Mar 31, 26$9.15Apr 2, 26$9.67Apr 7, 26$9.71Apr 9, 26$9.29Apr 13, 26$9.63Apr 15, 26$9.58Apr 17, 26$10.18Apr 22, 26$9.99Apr 24, 26$9.38Apr 28, 26$9.29Apr 30, 26$8.98May 4, 26$9.28May 6, 26$9.68May 8, 26$10.06May 12, 26$7.91May 14, 26$7.29May 18, 26$6.90May 20, 26$7.20May 22, 26$7.55May 28, 26$7.99Jun 1, 26$7.44Jun 3, 26$7.01Jun 5, 26$7.01Jun 9, 26$6.79Jun 11, 26$6.50Jun 15, 26$6.63Jun 17, 26$6.34Jun 22, 26$5.82Jun 24, 26$5.58Jun 26, 26$5.82Jul 2, 26$5.89
$5.5152-week range$49.05
Loading valuation history…

Fundamentals

Key fundamentals

$249.3M

Market cap

—

Revenue growth (YoY)

96.3%

Gross margin

-$70M

Free cash flow (USD)

-$292M

Net debt

Net cash position

35.4%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2019 → 2025

FY 2019$0.00FY 2020$0.00FY 2021$0.00FY 2022$15.0MFY 2023$0.00FY 2024$0.00FY 2025$19.1M
$0$19.1M

Free cash flow by year

2019 → 2025

FY 2019$-19.0KFY 2020$-10.3MFY 2021$-58.6MFY 2022$-94.6MFY 2023$-60.4MFY 2024$-59.9MFY 2025$-70.0M
-$19K-$70M

Gross margin by year

2022 → 2025

FY 2022100.0%FY 202596.3%
100.0%96.3%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 11, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventBoard Member ResignationJul 2, 2026Filing
  • 8-K eventAnnual Meeting ResultsJun 12, 2026Filing
  • 8-K eventEarnings ReleaseMay 11, 2026Filing
  • Quarterly report10-Q FiledMay 11, 2026Filing

Questions

Frequently asked questions

What is LENZ Therapeutics, Inc.'s market cap?

LENZ Therapeutics, Inc. (LENZ) has a market capitalization of $249.3M.

What is LENZ's P/E ratio?

A meaningful P/E ratio is not available for LENZ — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is LENZ's price-to-book (P/B) ratio?

LENZ trades at 0.88 times book value per share.

Are insiders buying LENZ stock?

SEC Form 4 filings show no open-market insider buys at LENZ Therapeutics, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

STRO

Sutro Biopharma, Inc.

$251.1M

FHTX

Foghorn Therapeutics Inc.

$253.6M

CGEN

Compugen Ltd.

$254.8M

ALEC

Alector, Inc.

$242.6M

CDXS

Codexis, Inc.

$258.1M

IVA

Inventiva S.A.

$259.9M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.